Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

CEAT - Replacement demand drives outperformance - ICICI Securities

Posted On: 2020-10-29 05:44:45

CEAT's Q2FY21 performance was an all-round beat on consensus expectations. EBIDTA margins came in at 14.8%. The strong margin performance was due to: a) improvement in product mix (replacement share up 30%); b) lower commodity prices on crude-linked derivatives (e.g. carbon black); and c) internal cost control. Management indicated ramping up operations to cater to OEM, replacement demand aided by import restrictions has supported volume growth. Strong operating cashflows, cost control measures and prudent capex are expected to help keep debt levels in check. Demand outlook for Q321E remains positive however management visibility for demand beyond the same remains low. Maintain BUY.

Key highlights of earnings call:

- The gross margin improvement was largely driven by: i) reduction in raw material costs (~5%), lower carbon black prices; ii) improved product mix (replacement segment grew 30% YoY) and iii) strong cost control measures.

- Management indicated likely margin pressure in Q3/Q4 as raw material costs edge higher by 2-3% QoQ (natural rubber up 28% MoM) and product mix shifts towards higher OEMs sales for the festive period.

- Income tax for Q2 was lower by Rs550mn, due to one-time impact of accumulated losses in CSTL consumed in Q2, as the company completes the merger of CSTL effective FY21. Effective tax rate for H2FY21 would trend higher to normal tax rate.

- Management indicated import restriction on tyres has aided domestic players as imports have gone down significantly. On M&HCV side, TBB segment has witness strong gains vis-à-vis TBR, CEAT's TBB capacity is operating at peak utilisations.

- Plant capacity and utilisation: In Halol plant, TBR segment currently operates at ~50% utilisation at 60k-70k units per month (total capacity 120k tyres); PCR currently operates at capacity of 20k tyres per day. In Chennai, PCR is operating at 3k-4k tyres per day on capacity of 20k tyres per day with another 10k units per day to be added in phase-2.

- CSTL business currently operates at 85-90% utilisation producing (30-35T per day) and will gradually be ramped up to 50-55T capacity in the current capex cycle.

- Company has reduced debt by Rs1.9bn to Rs18bn largely from operating cashflow management, reduction in working capital (Rs0.55bn) and delay in capex.

- Company has gained market share during the quarter (~16%) due to supply constraints in the industry and is likely to normalize at ~13-14% market share.

- CEAT plans for cost reduction of Rs1bn in utility costs, power and fuel costs, network redesign and employee costs, benefits of which will be visible in FY22E.


As we enter H2FY21, we like the growth rebound story however are apprehensive on maintenance of such high margin levels, believe as the mix normalises (OEM vis-à-vis replacement), margins are likely to mean revert lower (10-12% band). Commodity price inflation of natural rubber (up ~28% MoM) also remains a key risk. We tweak our earnings estimates downwards (12%/-2%/-3% for FY21E/FY22E/FY23E) factoring in weak growth outlook. We value CEAT on SoTP basis, maintain our standalone multiple to 15x Sep'22E EPS of Rs87 (earlier: Rs89) and maintain the ascribed value of Sri Lanka business at Rs22 per share. We maintain our BUY rating on the stock with a revised target price of Rs1,323 (earlier: Rs1,356).

Shares of CEAT LTD. was last trading in BSE at Rs.1105 as compared to the previous close of Rs. 1146.45. The total number of shares traded during the day was 5854 in over 812 trades.

The stock hit an intraday high of Rs. 1153.5 and intraday low of 1100.8. The net turnover during the day was Rs. 6593208.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Auto Sector - Monthly Volume Round-up - Nov 20 - Reliance Securities

What do brokerages say on Burger King India Limited's IPO?

The Phoenix Mills - Potential fund infusion may usher in growth - ICICI Securities

Godrej Agrovet - Beneficiary of 60% increase in palm oil prices - ICICI Securities

Automobiles (wholesale) - Wholesale dispatches rise amidst modest retail trends - ICICI Securities

Oil & Gas - Sector Update - Dec 2020 - ICICI Direct

Phoenix Mills (Buy): Asset monetisation at favourable terms... - ICICI Direct

Aditya Makharia's views on November Auto Sales Number for November 2020 - HDFC Securities

Burger King India - IPO Review - ICICI Direct

Quant Pick - LIC Housing Finance - ICICI Direct

Tech Mahindra - Analyst Meet Update - ICICI Direct

Gladiator Stocks - Crompton Greaves Consumer Electricals - ICICI Direct

Derivatives Monthly Outlook - Nifty support at 12800 for ongoing momentum...

Quant Pick - Sun Pharmaceuticals - ICICI Direct

Monetary Policy - Expectation from YES Securities

Sector Update on Asset Management Companies - Subdued but improvement expected - HDFC Securities

Pre Monetary Policy View - Dec, 2020 - Lakshmi Iyer, President and CIO (Debt) & Head Products, Kotak Mutual Fund

Maintain REDUCE on Siemens - Smart recovery priced in - HDFC Securities

Banking Sector Credit Trends - Growth continues to moderate - HDFC Securities

Q2 FY21 GDP: Light at the end of the tunnel - YES Securities

Siemens - Q4 FY20 Result Update - YES Securities

Super action in Home Loans - SBIN, ICICIBC, AXSB, HDFC and LICHF gaining share - YES Securities

Polymer price tracker - Dec 1, 2020 - PVC prices continue to tread higher - ICICI Securities

Bajaj Finance - Company Update - Dec 2020 - ICICI Direct

Siemens Ltd - Healthy revival in orders and margins - ICICI Securities

Covid Recovery Pulse - Nov 30, 2020 - Festive positivity continues in auto retails, e-way bill generation improves...

Derivatives Weekly View (November 27): Momentum expected to continue in broader markets with Nifty support at 12800...

Derivatives Strategy - Positional Option - ICICI Direct

Preview on RBI Monetary Policy - December 2020 - Shanti Ekambaram, Group President - Consumer Banking, Kotak Mahindra Bank

10 things you should know about Burger King India Limited

Views of HDFC Securities and Acuité Ratings & Research on Q2FY21 GDP Numbers

Rollover Report for November 2020 - December 2020: Angel Broking

Initiating Coverage on Godrej Properties - The housing factory - HDFC Securities

Burger King IPO - Angel Broking

Rollover Analysis - Record foreign inflows pushes Nifty to 13k - YES Securities

Ceramic tiles industry - Market share gains sustain for top branded players - ICICI Securities

Gas sector - CGD: Competition to hit margins, volumes and lead to derating - ICICI Securities

Cement - Prices resilient in Q3; consensus upgrades to continue - ICICI Securities

Specialty chemicals - Price trend in Sep-20 - ICICI Securities

Timken India - Q2FY21 Company Update - ICICI Direct

Upgrade in target price of IDFC First Bank - Angel Broking

Laurus Labs stake acquisition in Richore Lifesciences - Angel Broking

Shares of Lakshmi Vilas Bank (LVB) suspended from trading - Angel Broking

Initiating Coverage on Sundram Fasteners - Fastening growth - HDFC Securities

Astral Poly Technik - Scalability to further improve with storage tanks foray - ICICI Securities

Vardhman Special Steel - Q2FY21 Company Update - ICICI Direct

Initiating Coverage - Advanced Enzyme Technologies - ICICI Direct

L&T - Secures Large Contract - Nov 25, 2020 - Angel Broking

Alembic Pharmaceuticals - Tentative Approval for JV - Angel Broking

Drug launch by Lupin - Tacrolimus Capsules - Angel Broking

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019